Search Within

Stephen D Nimer

  1. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (69)
  2. Journal Article (50)
  3. Book Section (2)
Groups
  1. Center for Hematologic Malignancies (121)
  2. Department of Medicine (121)
  3. Hematologic Malignancies, Division of (121)
  4. Adult Leukemia (57)
  5. Survivorship Research (49)
  6. Lymphoma (41)

More Groups

People
  1. Andrew Zelenetz (40)
  2. Craig Moskowitz (39)
  3. Tarun Kewalramani (37)
  4. Hani Hassoun (31)
  5. Virginia Klimek (30)
  6. Joachim Yahalom (27)

More People

Years
  1. 2017 (1)
  2. 2013 (2)
  3. 2012 (9)
  4. 2011 (10)
  5. 2010 (9)
  6. 2009 (7)

More Years

Publications
  1. Blood (74)
  2. British Journal of Haematology (5)
  3. Journal of Clinical Oncology (5)
  4. Bone Marrow Transplantation (4)
  5. Amyloid (3)
  6. Haematologica (3)

More Publications

Publishers
  1. American Society of Hematology (74)
  2. Nature Publishing Group (8)
  3. American Association for Cancer Research (5)
  4. American Society of Clinical Oncology (5)
  5. John Wiley & Sons (5)
  6. Taylor & Francis Group (4)

More Publishers

Results (121)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Normalization of FDG-PET pre-ASCT with additional non-cross resistant chemotherapy improves EFS in patients with relapsed and primary refractory Hodgkin lymphoma - Memorial Sloan Kettering protocol 04-047
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; Portlock, C. S.; Straus, D. J.; Gerecitano, J.; Kewalramani, T.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Pre-transplant evaluation with both CT and PET following second-line therapy is essential for predicting outcome in patients with transplant-eligible relapsed and primary refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Nimer, S. D.; Zelenetz, A. D.; Kewalramani, T.; Vanak, J. M.; Maragulia, J. C.; Yahalom, J.; Moskowitz, C.
    Blood (2008)

    Fulltext@MSK | Save
  • Sequential administration of bortezomib, liposomal doxorubicin and dexamethasone (BDD) followed by thalidomide and dexamethasone (TD) results in rapid control of untreated high-risk multiple myeloma (MM) and improves depth of response
    Meeting Abstract

    Landau, H.; Hassoun, H.; Cohen, A.; Hoover, E.; Kewalramani, T.; Boruchov, A.; Klimek, V.; Reich, L.; Riedel, E.; Pandit-Taskar, N.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Early adjuvant treatment after risk-adapted autologous stem cell transplant for systemic light-chain amyloidosis: Increased hospitalizations and impaired immune recovery but improved responses and overall survival
    Meeting Abstract

    Hoffman, J. E.; Hassoun, H.; Landau, H.; Hoover, E.; Cohen, A.; Nimer, S.; Comenzo, R.
    Blood (2008)

    Fulltext@MSK | Save
  • CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy
    Journal Article

    Zhou, P.; Comenzo, R. L.; Olshen, A. B.; Bonvini, E.; Koenig, S.; Maslak, P. G.; Fleisher, M.; Hoffman, J.; Jhanwar, S.; Young, J. W.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (Romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Fircanis, S.; Maslak, P.; Guernah, I.; Baum, M.; Wu, N.; Panageas, K.; Wright, J. J.; Pandolfi, P. P.; Nimer, S. D.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease
    Journal Article

    Hassoun, H.; Flombaum, C.; D'Agati, V. D.; Rafferty, B. T.; Cohen, A.; Klimek, V. M.; Boruchov, A.; Kewalramani, T.; Reich, L.; Nimer, S. D.; more...
    Bone Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings
    Journal Article

    Castro-Malaspina, H.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K.; Chiu, M.; more...
    Biology of Blood and Marrow Transplantation (2008)

    Fulltext@MSK | Save
  • CD32B in multiple myeloma and systemic AL-amyloidosis
    Meeting Abstract

    Boruchov, A. M.; Zhou, P.; Olshen, A.; Rankin, C.; Bonvini, E.; Koenig, S.; Fleisher, M.; McKenzie, S.; Maslak, P.; Jhanwar, S.; more...
    Haematologica (2007)

    Fulltext@MSK | Save
  • Late relapses characterize autologous transplantation (ASCT) in first complete remission (CR) for peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Kewalramani, T.; Horwitz, S.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (2007)

    Fulltext@MSK | Save